This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors having structural formula (I), their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.
本发明涉及EP4型
前列腺素E2受体的高效选择性激动剂,其结构式为(I),以及它们或其制剂在治疗青光眼和其他与患者眼内压升高相关的疾病中的应用。本发明还涉及使用本发明化合物介导成骨细胞和破骨细胞的骨建模和重塑过程。